Advertisement

Crimson staff writer

Anjeli R. Macaranas

Crimson staff writer Anjeli R. Macaranas can be reached at anjeli.macaranas@thecrimson.com.

Latest Content

Gender and Sexuality

Title IX Complaints at Harvard Surge After Pandemic Low, Per Annual Report

Title IX disclosures and complaints to the University dropped significantly during the pandemic and subsequently increased, according to a report released on Tuesday.

Title IX

By the Numbers: Title IX Complaints at Harvard Since 2015

The number of Title IX disclosures at Harvard fell during the pandemic, only to shoot back up in Fiscal Year 2022. See Title IX disclosure data from the last six years.

Title IX Office
College

Higher Ed Institutions Call for Clarity, Simplicity in Title IX Amendments Proposed by Biden Administration

The American Council on Education submitted comments to the U.S. Department of Education Monday, calling for changes to the Title IX amendments proposed by the Biden administration in June.

OGE and ODR
College

Proposed Title IX Regulations Roll Back Trump-Era Policies, Raising Concerns Among Higher Education Experts

Faculty and experts expressed both praise and concern regarding the Biden Administration’s newly proposed changes to Title IX regulations on June 23.

Office of Gender Equity
Gender and Sexuality

Harvard Title IX Coordinator Apologizes for Statement on Comaroff Lawsuit

Harvard Title IX Coordinator Nicole M. Merhill apologized for a statement she made last week, writing that it “has contributed to further concerns around trust.”

HSPH 2
Health

Moderna Vaccine Slightly More Effective than Pfizer, Per HSPH Study

Researchers at Harvard’s T. H. Chan School of Public Health found earlier this month that Moderna’s coronavirus vaccine is slightly more effective than Pfizer’s at preventing negative Covid-19 outcomes.

Brigham and Women's Hospital
Health

BWH Researchers Launch First-Ever Human Trial for Alzheimer’s Nasal Vaccine

Brigham and Women’s Hospital will begin treating patients this week in the first human trial for a nasal vaccine to prevent and slow Alzheimer’s disease.

Medical School
Harvard Medical School

HMS Office for Community-Centered Medical Education Receives $150,000 Donation

Harvard Medical School received a $150,000 donation on Nov. 19 to support the current development of an office for community-centered medical education.

School of Public Health
Harvard Medical School

HSPH Announces Collaboration with Tsinghua Vanke School of Public Health in China

Harvard’s T.H. Chan School of Public Health announced a new academic and research collaboration with Tsinghua University’s Vanke School of Public Health in Beijing in a press release on Wednesday.

Harvard Dental School
Health

‘A Hard Stop’: How Harvard’s Dental School Graduated Every Student Despite a Pandemic Shutdown

Dental School faculty worked "day and night" to ensure students stayed afloat with limited clinical instruction.

Harvard Medical School
Harvard Medical School

HMS Affiliates Develop Global Covid-19 Clinical Education Video Series

Faculty at Harvard Medical School developed an online, evidence-based video series to provide clinical guidelines for health care providers around the world and combat misinformation surrounding the Covid-19 pandemic.

Medical School
Health

Harvard Epidemiologist Michael Mina Resigns, Appointed Chief Science Officer at eMed

Harvard epidemiologist Michael J. Mina is leaving academia for a leadership position at biotech software company eMed.

Mass General Hospital
Health

MGB Invests $50 Million in Local Health Initiatives with Focus on Equity

Mass General Brigham will invest $50 million in a new initiative focused on mental health, chronic disease management, and nutrition security, the hospital network announced last week.

Harvard Medical School
Research

HMS Researchers Develop AI Model to Detect Disease-Causing Gene Variants

Researchers at Harvard Medical School and Oxford University developed a new artificial intelligence model that can determine whether a gene variant is benign or disease-causing.

William V. Giannobile
Health

Dental School Dean Lauds Covid-19 Response, Diversity Efforts

William V. Giannobile, the dean of the Harvard School of Dental Medicine, talked the school’s response to the coronavirus pandemic, strides made in diversity and inclusion efforts, and the impact of Covid-19 on oral health care in a Monday interview.

Advertisement